Precipio, Inc. (PRPO) Earnings Call Analysis

NASDAQ · Unknown · Unknown

22/25

Growth 5 Margin 5 Expansion 4 Platform 4 Financial 4

latest quarter score

Earnings Reports

22
Precipio (PRPO) Q2 2026: Revenue Surpasses $7M as Product Sales Surge 35%, Driving Positive EBITDA and Cash Flow
August 18, 2026
19
Procipio (PRPO) Q4 2025: Gross Margin Jumps to 90% on Pathology Scale, Shifting to Growth Mode
June 15, 2026
11
Percipio (PRPO) Q1 2026: $3M Pipeline Added as Product Focus Drives Commercial Expansion
May 19, 2026
20
Precipio (PRPO) Q3 2025: EBITDA Turns Positive as Gross Margins Rise to 46%
November 18, 2025
14
Precipio (PRPO) Q1 2025: 43% Revenue Growth Drives Margin Expansion and Operational Efficiency
May 15, 2025

Browse all companies